Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 1 | Journal of Inflammation

Fig. 1

From: Emodin alleviates intestinal ischemia–reperfusion injury through antioxidant stress, anti-inflammatory responses and anti-apoptosis effects via Akt-mediated HO-1 upregulation

Fig. 1

A Histological morphological changes of the intestine in H&E staining (scale bar = 100 μm) were shown in the following groups: a sham group, b II/R model group, c II/R plus 20 mg/kg Emodin, d II/R plus 40 mg/kg Emodin, e II/R plus 80 mg/kg Emodin, f Chiu score was used to measure the extent of intestinal damage. B Intestinal edema was measured using the wet/dry weight ratio of the intestine. The intestinal edema increased after II/R injury. However, after the use of Emodin with different doses, the intestinal edema decreased to varying degrees. C Different doses of Emodin alleviated intestinal inflammation caused by II/R injury. Pro-inflammatory factors such as IL-6, TNF and IL-1β were decreased after the use of Emodin. D Different doses of Emodin attenuated II/R-associated oxidative stress and inflammation to varying degrees. The 40 mg/kg Emodin and 80 mg/kg Emodin attenuated II/R-associated oxidative stress more effectively than 20 mg/kg Emodin

Back to article page